Pfizer has not been entirely bought out or acquired as a whole entity in Pakistan; rather, like several global pharmaceutical multinationals operating in the region, it has selectively restructured portions of its manufacturing, local partnerships, and product portfolios in response to domestic regulatory policies and economic shifts.